Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer modelsPeng Xia, Jing Ai|Journal of Experimental & Clinical Cancer Research|2019Cited by 32
Circ_001653 alleviates sepsis associated-acute kidney injury by recruiting BUD13 to regulate KEAP1/NRF2/HO-1 signaling pathwayXinxin Li, Peng Xia|Journal of Inflammation|2024Cited by 12